<?xml version="1.0" encoding="UTF-8"?><faers xmlns="http://fda.gov/ns/faers"><meta><status>PENDING</status><version>v2</version><patient-age>64</patient-age><report-id>PHHO2005DE11666</report-id><gender>male</gender><reactions><reaction>Relapsing abdominal hernia</reaction><reaction>Aortic valve stenosis</reaction><reaction>Incarcerated hernia</reaction><reaction>There was an area of necrotic small intestine which he had excised</reaction><reaction>Subendocardial myocardial infarction without ST elevation</reaction><reaction>Hypervolaemia</reaction><reaction>Tachycardial arrhythmia</reaction><reaction>Angina</reaction><reaction>Adverse event toxicity</reaction><reaction>Seroma</reaction><reaction>Rejection</reaction><reaction>Arrhythmia absoluta</reaction><reaction>Non STEMI post surgery</reaction></reactions><drugs><drug><ndc>59572983</ndc><drug-name>CYCLOSPORIN</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>MYCOPHENOLATE MOFETIL</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>PREDNISOLONE</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>DACLIZUMAB</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>TACROLIMUS</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>PANTOZOL</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>BELOC ZOK</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>EUTHYROX</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>SPASMEX</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>UNACID</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>KEPINOL</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>ACETYLCYSTEINE</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>ASPIRIN</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>CIPROFLOXACIN</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>DIGITOXIN</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>FUROSEMID</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>FLUVASTATIN</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>KALIUM-DURILES</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>RISEDRONATE SODIUM</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>TEMAZEPAM</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>ISONIAZID</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>ENOXAPARIN SODIUM</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>CLOPIDOGREL</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>COLCHICUM AUTUMNALE</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>TORASEMIDE</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>SULTAMICILLIN</drug-name><manufacturer/><ingredients/></drug></drugs><indications><indication>Renal transplant</indication></indications><patient-age>64</patient-age><outcomes><outcome>Death</outcome><outcome>Life Threatening</outcome><outcome>Required Inpatient Hospitalization</outcome></outcomes><country>Germany</country><geo/></meta><original><ichicsr lang="en" xmlns="">
	<ichicsrmessageheader>
		<messagetype>ichicsr</messagetype>
		<messageformatversion>2.1</messageformatversion>
		<messageformatrelease>2.0</messageformatrelease>
		<messagenumb>4053178_286</messagenumb>
		<messagesenderidentifier>NovartisPH</messagesenderidentifier>
		<messagereceiveridentifier>ZZFDA</messagereceiveridentifier>
		<messagedateformat>204</messagedateformat>
		<messagedate>20121211134155</messagedate>
	</ichicsrmessageheader>
	<safetyreport>
		<safetyreportversion>5</safetyreportversion>
		<safetyreportid>PHHO2005DE11666</safetyreportid>
		<primarysourcecountry>DE</primarysourcecountry>
		<occurcountry>DE</occurcountry>
		<transmissiondateformat>102</transmissiondateformat>
		<transmissiondate>2012-12-11</transmissiondate>
		<reporttype>2</reporttype>
		<serious code="1">Yes</serious>
		<seriousnessdeath>1</seriousnessdeath>
		<seriousnesslifethreatening>1</seriousnesslifethreatening>
		<seriousnesshospitalization>1</seriousnesshospitalization>
		<seriousnessdisabling>2</seriousnessdisabling>
		<seriousnesscongenitalanomali>2</seriousnesscongenitalanomali>
		<seriousnessother>1</seriousnessother>
		<receivedateformat>102</receivedateformat>
		<receivedate>2005-07-26</receivedate>
		<receiptdateformat>102</receiptdateformat>
		<receiptdate>2012-12-06</receiptdate>
		<additionaldocument>2</additionaldocument>
		<fulfillexpeditecriteria>1</fulfillexpeditecriteria>
		<companynumb>PHHO2005DE11666</companynumb>
		<medicallyconfirm>1</medicallyconfirm>
		<primarysource>
			<reporterfamilyname>PRIVACY</reporterfamilyname>
			<reportercountry>DE</reportercountry>
			<qualification code="1">Physician</qualification>
			<observestudytype>3</observestudytype>
		</primarysource>
		<sender>
			<sendertype>1</sendertype>
			<senderorganization>NOVARTIS PHARMACEUTICAL CORPORATION</senderorganization>
			<senderdepartment>Clinical Safety and Epidemiology</senderdepartment>
			<senderfamilyname>Clinical Safety and Epidemiology</senderfamilyname>
			<senderstreetaddress>Novartis Pharmaceuticals Corp. Bldg 419, One Health Plaza</senderstreetaddress>
			<sendercity>East Hanover</sendercity>
			<senderstate>NJ</senderstate>
			<senderpostcode>07936</senderpostcode>
			<sendercountrycode>US</sendercountrycode>
			<sendertel>+1800378</sendertel>
			<sendertelextension>8567</sendertelextension>
			<sendertelcountrycode>US</sendertelcountrycode>
			<senderfax>+1973781</senderfax>
			<senderfaxextension>8001</senderfaxextension>
			<senderfaxcountrycode>US</senderfaxcountrycode>
			<senderemailaddress>gdss.configuration@pharma.novartis.com</senderemailaddress>
		</sender>
		<receiver>
			<receivertype>2</receivertype>
			<receiverorganization>ZZFDA</receiverorganization>
			<receiverdepartment>FDA</receiverdepartment>
			<receivertitle>Mr</receivertitle>
			<receivergivename>William</receivergivename>
			<receiverfamilyname>Taylor</receiverfamilyname>
			<receiverstreetaddress>5600 Fishers Lane Room 16B-45</receiverstreetaddress>
			<receivercity>Rockville</receivercity>
			<receiverstate>MD</receiverstate>
			<receiverpostcode>20857</receiverpostcode>
			<receivercountrycode>US</receivercountrycode>
			<receivertel>+1301827</receivertel>
			<receivertelextension>0964</receivertelextension>
			<receivertelcountrycode>US</receivertelcountrycode>
			<receiverfax>+1301594</receiverfax>
			<receiverfaxextension>0829</receiverfaxextension>
			<receiverfaxcountrycode>US</receiverfaxcountrycode>
			<receiveremailaddress>.</receiveremailaddress>
		</receiver>
		<patient>
			<patientinitial>--</patientinitial>
			<patientonsetage>64</patientonsetage>
			<patientonsetageunit>801</patientonsetageunit>
			<patientsex code="1">Male</patientsex>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Incisional drainage</patientepisodename>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Abdominal hernia repair</patientepisodename>
				<patientmedicalstartdateformat>102</patientmedicalstartdateformat>
				<patientmedicalstartdate>20041011</patientmedicalstartdate>
				<patientmedicalcontinue>2</patientmedicalcontinue>
				<patientmedicalenddateformat>102</patientmedicalenddateformat>
				<patientmedicalenddate>20060416</patientmedicalenddate>
			</medicalhistoryepisode>
			<patientdeath>
				<patientdeathdateformat>102</patientdeathdateformat>
				<patientdeathdate>20070216</patientdeathdate>
				<patientautopsyyesno>3</patientautopsyyesno>
				<patientdeathcause>
					<patientdeathreportmeddraversion>15.1</patientdeathreportmeddraversion>
					<patientdeathreport>Aortic valve stenosis</patientdeathreport>
				</patientdeathcause>
			</patientdeath>
			<reaction>
				<primarysourcereaction>Relapsing abdominal hernia</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Abdominal hernia</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Abdominal hernia</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20041103</reactionstartdate>
				<reactionenddateformat>102</reactionenddateformat>
				<reactionenddate>20060416</reactionenddate>
				<reactionduration>530</reactionduration>
				<reactiondurationunit>804</reactiondurationunit>
				<reactionfirsttime>127</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionoutcome code="1">recovered/resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Aortic valve stenosis</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Aortic valve stenosis</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Aortic valve stenosis</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20070129</reactionstartdate>
				<reactionfirsttime>944</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionoutcome code="5">fatal</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Incarcerated hernia</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Incarcerated hernia</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Hernia obstructive</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20060414</reactionstartdate>
				<reactionenddateformat>102</reactionenddateformat>
				<reactionenddate>20060509</reactionenddate>
				<reactionduration>26</reactionduration>
				<reactiondurationunit>804</reactiondurationunit>
				<reactionfirsttime>654</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionoutcome code="1">recovered/resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>There was an area of necrotic small intestine which he had excised</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Intestinal necrosis</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Gastrointestinal necrosis</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20060414</reactionstartdate>
				<reactionenddateformat>102</reactionenddateformat>
				<reactionenddate>20060416</reactionenddate>
				<reactionduration>3</reactionduration>
				<reactiondurationunit>804</reactiondurationunit>
				<reactionfirsttime>654</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionoutcome code="1">recovered/resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Subendocardial myocardial infarction without ST elevation</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Subendocardial myocardial infarction</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Myocardial infarction</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20040701</reactionstartdate>
				<reactionenddateformat>102</reactionenddateformat>
				<reactionenddate>20060503</reactionenddate>
				<reactionduration>672</reactionduration>
				<reactiondurationunit>804</reactiondurationunit>
				<reactionfirsttime>2</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionoutcome code="1">recovered/resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Hypervolaemia</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Hypervolaemia</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Hypervolaemia</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20050701</reactionstartdate>
				<reactionfirsttime>367</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionoutcome code="1">recovered/resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Tachycardial arrhythmia</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Tachyarrhythmia</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Tachyarrhythmia</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20050701</reactionstartdate>
				<reactionfirsttime>367</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionoutcome code="1">recovered/resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Angina</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Angina pectoris</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Angina pectoris</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20050701</reactionstartdate>
				<reactionfirsttime>367</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionoutcome code="1">recovered/resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Adverse event toxicity</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Drug toxicity</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Toxicity to various agents</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20041014</reactionstartdate>
				<reactionfirsttime>107</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Seroma</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Seroma</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Seroma</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Rejection</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Kidney transplant rejection</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Kidney transplant rejection</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Arrhythmia absoluta</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Arrhythmia absoluta</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Atrial fibrillation</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionoutcome code="3">not recovered/not resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Non STEMI post surgery</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Non STEMI</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Acute myocardial infarction</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20040715</reactionstartdate>
				<reactionenddateformat>102</reactionenddateformat>
				<reactionenddate>20041027</reactionenddate>
				<reactionduration>105</reactionduration>
				<reactiondurationunit>804</reactiondurationunit>
				<reactionfirsttime>16</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionoutcome code="1">recovered/resolved</reactionoutcome>
			</reaction>
			<test>
				<testname>Arteriogram coronary</testname>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testname>Investigation</testname>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testname>Troponin</testname>
				<testresult>0.68</testresult>
				<testunit>mg/ml</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testname>Troponin</testname>
				<testresult>0.68</testresult>
				<testunit>mg/ml</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>CYCLOSPORIN</medicinalproduct>
				<obtaindrugcountry>DE</obtaindrugcountry>
				<drugauthorizationnumb>50-715</drugauthorizationnumb>
				<drugauthorizationcountry>DE</drugauthorizationcountry>
				<drugauthorizationholder>NOVARTIS SECTOR: PHARMA</drugauthorizationholder>
				<drugstructuredosagenumb>170</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>2</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugcumulativedosagenumb>43180</drugcumulativedosagenumb>
				<drugcumulativedosageunit code="003">milligrams</drugcumulativedosageunit>
				<drugdosagetext>170 mg, BID</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Renal transplant</drugindication>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2004-06-30</drugstartdate>
				<drugstartperiod>127</drugstartperiod>
				<drugstartperiodunit>804</drugstartperiodunit>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>2004-11-05</drugenddate>
				<drugtreatmentduration>129</drugtreatmentduration>
				<drugtreatmentdurationunit code="804">Day</drugtreatmentdurationunit>
				<actiondrug code="1">Drug Withdrawn</actiondrug>
				<activesubstance>
					<activesubstancename>CICLOSPORIN</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Abdominal hernia</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Abdominal hernia</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Acute myocardial infarction</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Acute myocardial infarction</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Angina pectoris</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Angina pectoris</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Aortic valve stenosis</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Aortic valve stenosis</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Atrial fibrillation</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Atrial fibrillation</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Gastrointestinal necrosis</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Gastrointestinal necrosis</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Hernia obstructive</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Hernia obstructive</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Hypervolaemia</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Hypervolaemia</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Kidney transplant rejection</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Kidney transplant rejection</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Myocardial infarction</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Myocardial infarction</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Seroma</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Seroma</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Tachyarrhythmia</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Tachyarrhythmia</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Toxicity to various agents</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Toxicity to various agents</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
			</drug>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>MYCOPHENOLATE MOFETIL</medicinalproduct>
				<obtaindrugcountry>DE</obtaindrugcountry>
				<drugauthorizationcountry>DE</drugauthorizationcountry>
				<drugstructuredosagenumb>1</drugstructuredosagenumb>
				<drugstructuredosageunit code="002">grams</drugstructuredosageunit>
				<drugseparatedosagenumb>2</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugdosagetext>1 g, BID</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Renal transplant</drugindication>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2004-06-30</drugstartdate>
				<drugstartperiod>127</drugstartperiod>
				<drugstartperiodunit>804</drugstartperiodunit>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>2004-10-12</drugenddate>
				<drugtreatmentduration>105</drugtreatmentduration>
				<drugtreatmentdurationunit code="804">Day</drugtreatmentdurationunit>
				<actiondrug code="2">Dose Reduced</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>MYCOPHENOLATE MOFETIL</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>MYCOPHENOLATE MOFETIL</medicinalproduct>
				<obtaindrugcountry>DE</obtaindrugcountry>
				<drugauthorizationcountry>DE</drugauthorizationcountry>
				<drugstructuredosagenumb>250</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>2</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugdosagetext>250 mg, BID</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2004-10-13</drugstartdate>
				<drugstartperiod>127</drugstartperiod>
				<drugstartperiodunit>804</drugstartperiodunit>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>2005-05-19</drugenddate>
				<drugtreatmentduration>219</drugtreatmentduration>
				<drugtreatmentdurationunit code="804">Day</drugtreatmentdurationunit>
				<actiondrug code="2">Dose Reduced</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>MYCOPHENOLATE MOFETIL</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>MYCOPHENOLATE MOFETIL</medicinalproduct>
				<obtaindrugcountry>DE</obtaindrugcountry>
				<drugauthorizationcountry>DE</drugauthorizationcountry>
				<drugstructuredosagenumb>1000</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>1</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugdosagetext>1000 mg, QD</drugdosagetext>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2006-05-26</drugstartdate>
				<drugstartperiod>127</drugstartperiod>
				<drugstartperiodunit>804</drugstartperiodunit>
				<actiondrug code="2">Dose Reduced</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>MYCOPHENOLATE MOFETIL</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>PREDNISOLONE</medicinalproduct>
				<obtaindrugcountry>DE</obtaindrugcountry>
				<drugauthorizationcountry>DE</drugauthorizationcountry>
				<drugstructuredosagenumb>250</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>1</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugcumulativedosagenumb>11975</drugcumulativedosagenumb>
				<drugcumulativedosageunit code="003">milligrams</drugcumulativedosageunit>
				<drugdosagetext>500 mg, QD</drugdosagetext>
				<drugadministrationroute code="042">Intravenous (not otherwise specified)</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Renal transplant</drugindication>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2004-06-30</drugstartdate>
				<drugstartperiod>127</drugstartperiod>
				<drugstartperiodunit>804</drugstartperiodunit>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>2004-07-01</drugenddate>
				<drugtreatmentduration>2</drugtreatmentduration>
				<drugtreatmentdurationunit code="804">Day</drugtreatmentdurationunit>
				<actiondrug code="2">Dose Reduced</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>PREDNISOLONE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>PREDNISOLONE</medicinalproduct>
				<obtaindrugcountry>DE</obtaindrugcountry>
				<drugauthorizationcountry>DE</drugauthorizationcountry>
				<drugstructuredosagenumb>75</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>1</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugcumulativedosagenumb>11975</drugcumulativedosagenumb>
				<drugcumulativedosageunit code="003">milligrams</drugcumulativedosageunit>
				<drugdosagetext>75 mg, QD</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2004-07-01</drugstartdate>
				<drugstartperiod>127</drugstartperiod>
				<drugstartperiodunit>804</drugstartperiodunit>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>2004-07-01</drugenddate>
				<drugtreatmentduration>1</drugtreatmentduration>
				<drugtreatmentdurationunit code="804">Day</drugtreatmentdurationunit>
				<actiondrug code="2">Dose Reduced</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>PREDNISOLONE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>PREDNISOLONE</medicinalproduct>
				<obtaindrugcountry>DE</obtaindrugcountry>
				<drugauthorizationcountry>DE</drugauthorizationcountry>
				<drugstructuredosagenumb>100</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>1</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugcumulativedosagenumb>11975</drugcumulativedosagenumb>
				<drugcumulativedosageunit code="003">milligrams</drugcumulativedosageunit>
				<drugdosagetext>100 mg, QD</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2004-07-02</drugstartdate>
				<drugstartperiod>127</drugstartperiod>
				<drugstartperiodunit>804</drugstartperiodunit>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>2004-10-18</drugenddate>
				<drugtreatmentduration>109</drugtreatmentduration>
				<drugtreatmentdurationunit code="804">Day</drugtreatmentdurationunit>
				<actiondrug code="2">Dose Reduced</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>PREDNISOLONE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>PREDNISOLONE</medicinalproduct>
				<obtaindrugcountry>DE</obtaindrugcountry>
				<drugauthorizationcountry>DE</drugauthorizationcountry>
				<drugstructuredosagenumb>250</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>1</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugcumulativedosagenumb>11975</drugcumulativedosagenumb>
				<drugcumulativedosageunit code="003">milligrams</drugcumulativedosageunit>
				<drugdosagetext>250 mg, QD</drugdosagetext>
				<drugadministrationroute code="042">Intravenous (not otherwise specified)</drugadministrationroute>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2004-10-19</drugstartdate>
				<drugstartperiod>127</drugstartperiod>
				<drugstartperiodunit>804</drugstartperiodunit>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>2004-10-20</drugenddate>
				<drugtreatmentduration>2</drugtreatmentduration>
				<drugtreatmentdurationunit code="804">Day</drugtreatmentdurationunit>
				<actiondrug code="2">Dose Reduced</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>PREDNISOLONE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>PREDNISOLONE</medicinalproduct>
				<obtaindrugcountry>DE</obtaindrugcountry>
				<drugauthorizationcountry>DE</drugauthorizationcountry>
				<drugcumulativedosagenumb>11975</drugcumulativedosagenumb>
				<drugcumulativedosageunit code="003">milligrams</drugcumulativedosageunit>
				<drugdosagetext>NO TREATMENT</drugdosagetext>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2004-10-21</drugstartdate>
				<drugstartperiod>127</drugstartperiod>
				<drugstartperiodunit>804</drugstartperiodunit>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>2004-10-21</drugenddate>
				<drugtreatmentduration>1</drugtreatmentduration>
				<drugtreatmentdurationunit code="804">Day</drugtreatmentdurationunit>
				<actiondrug code="2">Dose Reduced</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>PREDNISOLONE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>PREDNISOLONE</medicinalproduct>
				<obtaindrugcountry>DE</obtaindrugcountry>
				<drugauthorizationcountry>DE</drugauthorizationcountry>
				<drugstructuredosagenumb>100</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>1</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugcumulativedosagenumb>11975</drugcumulativedosagenumb>
				<drugcumulativedosageunit code="003">milligrams</drugcumulativedosageunit>
				<drugdosagetext>100 mg, QD</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2004-10-22</drugstartdate>
				<drugstartperiod>127</drugstartperiod>
				<drugstartperiodunit>804</drugstartperiodunit>
				<actiondrug code="2">Dose Reduced</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>PREDNISOLONE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>DACLIZUMAB</medicinalproduct>
				<obtaindrugcountry>DE</obtaindrugcountry>
				<drugauthorizationcountry>DE</drugauthorizationcountry>
				<drugstructuredosagenumb>2</drugstructuredosagenumb>
				<drugstructuredosageunit code="007"/>
				<drugseparatedosagenumb>1</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="813">Total</drugintervaldosagedefinition>
				<drugdosagetext>2 mg/kg, (170mg) ONCE</drugdosagetext>
				<drugadministrationroute code="042">Intravenous (not otherwise specified)</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Renal transplant</drugindication>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2004-06-30</drugstartdate>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>2004-07-13</drugenddate>
				<drugtreatmentduration>14</drugtreatmentduration>
				<drugtreatmentdurationunit code="804">Day</drugtreatmentdurationunit>
				<actiondrug code="2">Dose Reduced</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>DACLIZUMAB</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>DACLIZUMAB</medicinalproduct>
				<obtaindrugcountry>DE</obtaindrugcountry>
				<drugauthorizationcountry>DE</drugauthorizationcountry>
				<drugstructuredosagenumb>85</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugdosagetext>85 mg, once per 2 weeks for 4 weeks</drugdosagetext>
				<drugadministrationroute code="042">Intravenous (not otherwise specified)</drugadministrationroute>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2004-07-14</drugstartdate>
				<actiondrug code="2">Dose Reduced</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>DACLIZUMAB</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>TACROLIMUS</medicinalproduct>
				<obtaindrugcountry>DE</obtaindrugcountry>
				<drugauthorizationcountry>DE</drugauthorizationcountry>
				<drugdosagetext>UNK, UNK</drugdosagetext>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Renal transplant</drugindication>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2004-11-04</drugstartdate>
				<actiondrug code="5">Unknown</actiondrug>
				<activesubstance>
					<activesubstancename>TACROLIMUS</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>PANTOZOL</medicinalproduct>
				<obtaindrugcountry>DE</obtaindrugcountry>
				<drugauthorizationcountry>DE</drugauthorizationcountry>
				<actiondrug code="4">Dose not changed</actiondrug>
				<activesubstance>
					<activesubstancename>PANTOPRAZOLE SODIUM</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>BELOC ZOK</medicinalproduct>
				<obtaindrugcountry>DE</obtaindrugcountry>
				<drugauthorizationcountry>DE</drugauthorizationcountry>
				<actiondrug code="5">Unknown</actiondrug>
				<activesubstance>
					<activesubstancename>METOPROLOL SUCCINATE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>EUTHYROX</medicinalproduct>
				<obtaindrugcountry>DE</obtaindrugcountry>
				<drugauthorizationcountry>DE</drugauthorizationcountry>
				<actiondrug code="5">Unknown</actiondrug>
				<activesubstance>
					<activesubstancename>LEVOTHYROXINE SODIUM</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>SPASMEX</medicinalproduct>
				<obtaindrugcountry>DE</obtaindrugcountry>
				<drugauthorizationcountry>DE</drugauthorizationcountry>
				<actiondrug code="5">Unknown</actiondrug>
				<activesubstance>
					<activesubstancename>TROSPIUM CHLORIDE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>UNACID</medicinalproduct>
				<obtaindrugcountry>DE</obtaindrugcountry>
				<drugauthorizationcountry>DE</drugauthorizationcountry>
				<actiondrug code="5">Unknown</actiondrug>
				<activesubstance>
					<activesubstancename>AMPICILLIN SODIUM, SULBACTAM SODIUM</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>KEPINOL</medicinalproduct>
				<obtaindrugcountry>DE</obtaindrugcountry>
				<drugauthorizationcountry>DE</drugauthorizationcountry>
				<actiondrug code="5">Unknown</actiondrug>
				<activesubstance>
					<activesubstancename>SULFAMETHOXAZOLE, TRIMETHOPRIM</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>ACETYLCYSTEINE</medicinalproduct>
				<obtaindrugcountry>DE</obtaindrugcountry>
				<drugauthorizationcountry>DE</drugauthorizationcountry>
				<actiondrug code="5">Unknown</actiondrug>
				<activesubstance>
					<activesubstancename>ACETYLCYSTEINE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>ASPIRIN</medicinalproduct>
				<obtaindrugcountry>DE</obtaindrugcountry>
				<drugauthorizationcountry>DE</drugauthorizationcountry>
				<actiondrug code="5">Unknown</actiondrug>
				<activesubstance>
					<activesubstancename>ACETYLSALICYLIC ACID</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>CIPROFLOXACIN</medicinalproduct>
				<obtaindrugcountry>DE</obtaindrugcountry>
				<drugauthorizationcountry>DE</drugauthorizationcountry>
				<actiondrug code="5">Unknown</actiondrug>
				<activesubstance>
					<activesubstancename>CIPROFLOXACIN</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>DIGITOXIN</medicinalproduct>
				<obtaindrugcountry>DE</obtaindrugcountry>
				<drugauthorizationcountry>DE</drugauthorizationcountry>
				<actiondrug code="5">Unknown</actiondrug>
				<activesubstance>
					<activesubstancename>DIGITOXIN</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>FUROSEMID</medicinalproduct>
				<obtaindrugcountry>DE</obtaindrugcountry>
				<drugauthorizationcountry>DE</drugauthorizationcountry>
				<actiondrug code="5">Unknown</actiondrug>
				<activesubstance>
					<activesubstancename>FUROSEMIDE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>FLUVASTATIN</medicinalproduct>
				<obtaindrugcountry>DE</obtaindrugcountry>
				<drugauthorizationcountry>DE</drugauthorizationcountry>
				<actiondrug code="5">Unknown</actiondrug>
				<activesubstance>
					<activesubstancename>FLUVASTATIN</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>KALIUM-DURILES</medicinalproduct>
				<obtaindrugcountry>DE</obtaindrugcountry>
				<drugauthorizationcountry>DE</drugauthorizationcountry>
				<actiondrug code="5">Unknown</actiondrug>
				<activesubstance>
					<activesubstancename>POTASSIUM CHLORIDE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>RISEDRONATE SODIUM</medicinalproduct>
				<obtaindrugcountry>DE</obtaindrugcountry>
				<drugauthorizationcountry>DE</drugauthorizationcountry>
				<actiondrug code="5">Unknown</actiondrug>
				<activesubstance>
					<activesubstancename>RISEDRONATE SODIUM</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>TEMAZEPAM</medicinalproduct>
				<obtaindrugcountry>DE</obtaindrugcountry>
				<drugauthorizationcountry>DE</drugauthorizationcountry>
				<actiondrug code="5">Unknown</actiondrug>
				<activesubstance>
					<activesubstancename>TEMAZEPAM</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>ISONIAZID</medicinalproduct>
				<obtaindrugcountry>DE</obtaindrugcountry>
				<drugauthorizationcountry>DE</drugauthorizationcountry>
				<actiondrug code="5">Unknown</actiondrug>
				<activesubstance>
					<activesubstancename>ISONIAZID</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>ENOXAPARIN SODIUM</medicinalproduct>
				<obtaindrugcountry>DE</obtaindrugcountry>
				<drugauthorizationcountry>DE</drugauthorizationcountry>
				<actiondrug code="5">Unknown</actiondrug>
				<activesubstance>
					<activesubstancename>ENOXAPARIN SODIUM, HEPARIN-FRACTION, SODIUM SALT</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>CLOPIDOGREL</medicinalproduct>
				<obtaindrugcountry>DE</obtaindrugcountry>
				<drugauthorizationcountry>DE</drugauthorizationcountry>
				<actiondrug code="5">Unknown</actiondrug>
				<activesubstance>
					<activesubstancename>CLOPIDOGREL</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>COLCHICUM AUTUMNALE</medicinalproduct>
				<obtaindrugcountry>DE</obtaindrugcountry>
				<drugauthorizationcountry>DE</drugauthorizationcountry>
				<actiondrug code="5">Unknown</actiondrug>
				<activesubstance>
					<activesubstancename>COLCHICUM AUTUMNALE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>TORASEMIDE</medicinalproduct>
				<obtaindrugcountry>DE</obtaindrugcountry>
				<drugauthorizationcountry>DE</drugauthorizationcountry>
				<actiondrug code="5">Unknown</actiondrug>
				<activesubstance>
					<activesubstancename>TORASEMIDE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>SULTAMICILLIN</medicinalproduct>
				<obtaindrugcountry>DE</obtaindrugcountry>
				<drugauthorizationcountry>DE</drugauthorizationcountry>
				<actiondrug code="5">Unknown</actiondrug>
				<activesubstance>
					<activesubstancename>SULTAMICILLIN</activesubstancename>
				</activesubstance>
			</drug>
			<summary>
				<narrativeincludeclinical><Semaphore x="1938518" class="Disease or Finding" value="First-Degree Burn" score="1.00" ID="C76130">Initial </Semaphore>report received on 26 Jul 2005: Report from a Non Novartis trial. Patient number 161045 was enrolled in the Elite Symphony study, evaluating the safety and efficacy of <Semaphore x="894462" class="Medicine" value="mycophenolate mofetil" score="1.00" ID="279461">mycophenolate mofetil</Semaphore>, <Semaphore x="428474" class="Medicine" value="Daclizumab" score="1.00" ID="240020">daclizumab </Semaphore>and corticosteroids as mainstay <Semaphore x="2048374" class="Procedure" value="Immunosuppressive Therapy" score="1.00" ID="C15261">immunosuppression </Semaphore>in combination with <Semaphore x="2125081" class="Procedure" value="Low-Dose Treatment" score="1.00" ID="C49341">low dose </Semaphore><Semaphore x="423457" class="Medicine" value="cycloSPORINE" score="0.93" ID="243146">cyclosporine</Semaphore>, <Semaphore x="1244668" class="Medicine" value="Tacrolimus" score="1.00" ID="268063">tacrolimus </Semaphore>or <Semaphore x="1186060" class="Medicine" value="Sirolimus" score="0.49" ID="258426">sirolimus </Semaphore>in comparison to <Semaphore x="1875899" class="Disease or Finding" value="Electrical Exposure" score="1.00" ID="C45407">current </Semaphore>standard <Semaphore x="2048374" class="Procedure" value="Immunosuppressive Therapy" score="1.00" ID="C15261">immunosuppression </Semaphore>(<Semaphore x="894462" class="Medicine" value="mycophenolate mofetil" score="1.00" ID="279461">mycophenolate mofetil</Semaphore>, <Semaphore x="423457" class="Medicine" value="cycloSPORINE" score="0.93" ID="243146">cyclosporine </Semaphore>and corticosteroids) in <Semaphore x="2087035" class="Disease or Finding" value="Kidney and Ureter Neoplasm" score="1.00" ID="C7514">renal transplantation</Semaphore>. The patient was concomitantly taking <Semaphore x="470273" class="Medicine" value="Digitoxin" score="0.49" ID="256814">digitoxin</Semaphore>, <Semaphore x="608230" class="Medicine" value="Furosemide" score="0.49" ID="269027">furosemide </Semaphore>and <Semaphore x="1066533" class="Medicine - Potassium Chloride - Dose" value="65 year old" score="0.49" ID=""><Semaphore x="1848940" class="Procedure" value="Dietary Protocol" score="1.00" ID="C93051">potassium </Semaphore><Semaphore x="1771945" class="Procedure" value="Chloride Measurement" score="1.00" ID="C64495">chloride</Semaphore>. A <Semaphore x="1387834" class="Patient Age" value="65" score="1.00" ID=""><Semaphore x="5960701642276865" class="Patient Age" value="65" score="1.00" ID="">65 </Semaphore>year old </Semaphore></Semaphore><Semaphore x="4582064384901121" class="Medicine - Potassium Chloride - Frequency" value="male" score="0.49" ID="">male </Semaphore>patient experienced a life threatening subendocardial myocardial <Semaphore x="3033151" class="MedDRA LLT" value="Infection" score="1.00" ID="10021789">infection </Semaphore>(reported term: <Semaphore x="2715903" class="MedDRA LLT" value="Acute myocardial infarction" score="1.00" ID="10000891">non <Semaphore x="2253052" class="Disease or Finding" value="Myocardial Infarction by ECG Finding" score="1.00" ID="C101589">STEMI</Semaphore></Semaphore>), <Semaphore x="2766382" class="MedDRA LLT" value="Atrial fibrillation" score="1.00" ID="10003658"><Semaphore x="1544130" class="Disease or Finding" value="Arrhythmia" score="1.00" ID="C2881">arrhythmia </Semaphore>absoluta </Semaphore>and a relapsing <Semaphore x="1405612" class="Disease or Finding" value="Abdominal Hernia" score="1.00" ID="C98700">abdominal hernia </Semaphore>during participation in the above study. He underwent <Semaphore x="2087035" class="Disease or Finding" value="Kidney and Ureter Neoplasm" score="1.00" ID="C7514">renal transplantation </Semaphore>on 30 June 2004 and received one 2 mg/kg dose of intravenous (IV) <Semaphore x="428474" class="Medicine" value="Daclizumab" score="1.00" ID="240020">daclizumab</Semaphore>, as per protocol and 250 mg IV <Semaphore x="1081705" class="Medicine" value="prednisoLONE" score="1.00" ID="291320">prednisolone</Semaphore>. <Semaphore x="2336704" class="AnatomicStructure" value="Oral Cavity" score="1.00" ID="C12421">Oral </Semaphore><Semaphore x="894462" class="Medicine" value="mycophenolate mofetil" score="1.00" ID="279461">mycophenolate mofetil </Semaphore>and ciclosporin (Novartis product) were commenced at 1 gram and 170 mg twice daily respectively. On post operative day 1, he received a second dose of IV <Semaphore x="1081705" class="Medicine" value="prednisoLONE" score="1.00" ID="291320">prednisolone </Semaphore>and <Semaphore x="2336704" class="AnatomicStructure" value="Oral Cavity" score="1.00" ID="C12421">oral </Semaphore><Semaphore x="1081705" class="Medicine" value="prednisoLONE" score="1.00" ID="291320">prednisolone </Semaphore>was commenced at 75 mg once daily. He developed <Semaphore x="3020129" class="MedDRA LLT" value="Hypervolaemia" score="1.00" ID="10020919">hypervolaemia</Semaphore>, "tachycardial <Semaphore x="1544130" class="Disease or Finding" value="Arrhythmia" score="1.00" ID="C2881">arrhythmia </Semaphore>and <Semaphore x="1525451" class="Disease or Finding" value="Angina" score="1.00" ID="C51221">angina</Semaphore>" with a "positive <Semaphore x="3289208" class="MedDRA LLT" value="Troponin" score="1.00" ID="10061576">troponin</Semaphore>" <Semaphore x="1910095" class="Disease or Finding" value="Experimental Result" score="1.00" ID="C76125">result </Semaphore>(0.68 mg/mL). Conservative <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">treatment </Semaphore>was commenced with anti <Semaphore x="1525451" class="Disease or Finding" value="Angina" score="1.00" ID="C51221">angina </Semaphore><Semaphore x="1670730" class="Procedure" value="CAM Pharmacological or Biological Treatment" score="1.00" ID="C15906">drugs </Semaphore>and he underwent <Semaphore x="1814460" class="Procedure" value="Coronary Angiography" score="1.00" ID="C100085">diagnostic <Semaphore x="2742940" class="MedDRA LLT" value="Angiogram" score="1.00" ID="10061637">angiography </Semaphore>of the <Semaphore x="1814691" class="AnatomicStructure" value="Coronary Artery" score="1.00" ID="C12843">coronary </Semaphore></Semaphore>
    <Semaphore x="1814691" class="AnatomicStructure" value="Coronary Artery" score="1.00" ID="C12843">arteries</Semaphore>. Due to minimal <Semaphore x="3289208" class="MedDRA LLT" value="Troponin" score="1.00" ID="10061576">troponin </Semaphore>elevation, the <Semaphore x="1846062" class="Procedure" value="Diagnosis" score="1.00" ID="C15220">diagnosis </Semaphore>was a life threatening <Semaphore x="3120463" class="MedDRA LLT" value="Myocardial infarction" score="1.00" ID="10028596">myocardial infarction </Semaphore>without ST elevation, which <Semaphore x="2066319" class="Disease or Finding" value="Intervention Required" score="1.00" ID="C52668">required intervention</Semaphore>. This event was considered to have resolved on post operative day 22. On an unspecified date, the patient developed an <Semaphore x="1405612" class="Disease or Finding" value="Abdominal Hernia" score="1.00" ID="C98700">abdominal hernia </Semaphore>and a planned correction was performed on 11 October 2004. Three days later, <Semaphore x="894462" class="Medicine" value="mycophenolate mofetil" score="1.00" ID="279461">mycophenolate mofetil </Semaphore>was decreased to 250 mg twice daily "due to <Semaphore x="2724216" class="MedDRA LLT" value="Adverse event" score="1.00" ID="10060933">adverse event </Semaphore><Semaphore x="2638558" class="Disease or Finding" value="Toxicity" score="1.00" ID="C27990">toxicity</Semaphore>". Approximately two weeks later, on 03 November 2004 he was admitted to hospital with a relapsing <Semaphore x="1405612" class="Disease or Finding" value="Abdominal Hernia" score="1.00" ID="C98700">abdominal hernia</Semaphore>, which was now considered to be serious. He also developed a <Semaphore x="2505848" class="Disease or Finding" value="Seroma" score="1.00" ID="C50739">seroma</Semaphore>, for which punctuation was done. Two days later, ciclosporin was switched to <Semaphore x="1244668" class="Medicine" value="Tacrolimus" score="1.00" ID="268063">tacrolimus</Semaphore>. The investigator stated that a second <Semaphore x="2022961" class="Disease or Finding" value="Hernia" score="1.00" ID="C34685">hernia </Semaphore>correction was not performed during this <Semaphore x="3012166" class="MedDRA LLT" value="Hospitalisation" score="1.00" ID="10054112">hospitalisation </Semaphore>due to ongoing high dose steroids following rejection and also because of the change in medication from ciclosporin to <Semaphore x="1244668" class="Medicine" value="Tacrolimus" score="1.00" ID="268063">tacrolimus</Semaphore>. Six days later, he was discharged from hospital. On 14 November 2004 he was hospitalised for a planned correction of the <Semaphore x="2022961" class="Disease or Finding" value="Hernia" score="1.00" ID="C34685">hernia</Semaphore>. However, 'cardial diagnostics had to be done before the <Semaphore x="2596409" class="Procedure" value="Surgical Procedure" score="1.00" ID="C15329">operation </Semaphore>and the following day he was reported to have <Semaphore x="2766382" class="MedDRA LLT" value="Atrial fibrillation" score="1.00" ID="10003658"><Semaphore x="1544130" class="Disease or Finding" value="Arrhythmia" score="1.00" ID="C2881">arrhythmia </Semaphore>absoluta</Semaphore>. As a <Semaphore x="1910095" class="Disease or Finding" value="Experimental Result" score="1.00" ID="C76125">result </Semaphore>of the <Semaphore x="2766382" class="MedDRA LLT" value="Atrial fibrillation" score="1.00" ID="10003658"><Semaphore x="1544130" class="Disease or Finding" value="Arrhythmia" score="1.00" ID="C2881">arrhythmia </Semaphore>absoluta</Semaphore>, the second <Semaphore x="2022961" class="Disease or Finding" value="Hernia" score="1.00" ID="C34685">hernia </Semaphore>correction was not performed. He received <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">treatment </Semaphore>with <Semaphore x="530331" class="Medicine" value="Enoxaparin sodium" score="0.49" ID="249134">enoxaparin <Semaphore x="1880026" class="Procedure" value="Electrolyte Measurement" score="0.58" ID="C74946">sodium </Semaphore></Semaphore>(Clexane), <Semaphore x="1848940" class="Procedure" value="Dietary Protocol" score="1.00" ID="C93051">potassium </Semaphore><Semaphore x="1587060" class="Procedure" value="Bicarbonate Measurement" score="1.00" ID="C74667">bicarbonate </Semaphore>(Kalitrans), <Semaphore x="2812633" class="MedDRA LLT" value="Blood magnesium" score="1.00" ID="10005651">magnesium </Semaphore>(<Semaphore x="2812633" class="MedDRA LLT" value="Blood magnesium" score="1.00" ID="10005651">magnesium </Semaphore>verla) and the dose of <Semaphore x="869530" class="Medicine" value="metoprolol succinate" score="0.49" ID="249149">metoprolol succinate </Semaphore>(Belok Zok), which he was already taking (non suspect <Semaphore x="1670730" class="Procedure" value="CAM Pharmacological or Biological Treatment" score="1.00" ID="C15906">drug</Semaphore>) was increased. The dosages of <Semaphore x="2336704" class="AnatomicStructure" value="Oral Cavity" score="1.00" ID="C12421">oral </Semaphore><Semaphore x="1081705" class="Medicine" value="prednisoLONE" score="1.00" ID="291320">prednisolone </Semaphore>and <Semaphore x="423457" class="Medicine" value="cycloSPORINE" score="0.93" ID="243146">cyclosporine </Semaphore>had been altered <Semaphore x="2199735" class="Race" value="Manzanita" score="1.00" ID="C44529">several </Semaphore>times, and were ongoing and he had received <Semaphore x="2199735" class="Race" value="Manzanita" score="1.00" ID="C44529">several </Semaphore>further 250 mg doses of IV <Semaphore x="1081705" class="Medicine" value="prednisoLONE" score="1.00" ID="291320">prednisolone </Semaphore>due to rejection episodes. No further information was available. At the time of the report, the relapsing <Semaphore x="1405612" class="Disease or Finding" value="Abdominal Hernia" score="1.00" ID="C98700">abdominal hernia </Semaphore>and the "<Semaphore x="2766382" class="MedDRA LLT" value="Atrial fibrillation" score="1.00" ID="10003658"><Semaphore x="1544130" class="Disease or Finding" value="Arrhythmia" score="1.00" ID="C2881">arrhythmia </Semaphore>absoluta</Semaphore>" were persisting and <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">treatment </Semaphore>with <Semaphore x="894462" class="Medicine" value="mycophenolate mofetil" score="1.00" ID="279461">mycophenolate mofetil</Semaphore>, <Semaphore x="1081705" class="Medicine" value="prednisoLONE" score="1.00" ID="291320">prednisolone </Semaphore>and <Semaphore x="1244668" class="Medicine" value="Tacrolimus" score="1.00" ID="268063">tacrolimus </Semaphore>were ongoing. The investigator considered the <Semaphore x="2253052" class="Disease or Finding" value="Myocardial Infarction by ECG Finding" score="1.00" ID="C101589">myocardial infarction </Semaphore>and <Semaphore x="2451967" class="Disease or Finding" value="Recurrent Disease, Distant Site" score="1.00" ID="C55073">relapsing </Semaphore><Semaphore x="1405612" class="Disease or Finding" value="Abdominal Hernia" score="1.00" ID="C98700">abdominal hernia </Semaphore>to be medically significant. The investigator considered the <Semaphore x="2253052" class="Disease or Finding" value="Myocardial Infarction by ECG Finding" score="1.00" ID="C101589">myocardial infarction </Semaphore>to be unrelated to <Semaphore x="428474" class="Medicine" value="Daclizumab" score="1.00" ID="240020">daclizumab</Semaphore>, <Semaphore x="894462" class="Medicine" value="mycophenolate mofetil" score="1.00" ID="279461">mycophenolate mofetil</Semaphore>, ciclosporin and <Semaphore x="1081705" class="Medicine" value="prednisoLONE" score="1.00" ID="291320">prednisolone</Semaphore>, but the relapsing <Semaphore x="1405612" class="Disease or Finding" value="Abdominal Hernia" score="1.00" ID="C98700">abdominal hernia </Semaphore>was considered related to <Semaphore x="894462" class="Medicine" value="mycophenolate mofetil" score="1.00" ID="279461">mycophenolate mofetil</Semaphore>, ciclosporin and <Semaphore x="1081705" class="Medicine" value="prednisoLONE" score="1.00" ID="291320">prednisolone </Semaphore>and unrelated to <Semaphore x="428474" class="Medicine" value="Daclizumab" score="1.00" ID="240020">daclizumab</Semaphore>. The investigator considered <Semaphore x="2766382" class="MedDRA LLT" value="Atrial fibrillation" score="1.00" ID="10003658"><Semaphore x="1544130" class="Disease or Finding" value="Arrhythmia" score="1.00" ID="C2881">arrhythmia </Semaphore>absoluta </Semaphore>to be unrelated to <Semaphore x="428474" class="Medicine" value="Daclizumab" score="1.00" ID="240020">daclizumab</Semaphore>, <Semaphore x="894462" class="Medicine" value="mycophenolate mofetil" score="1.00" ID="279461">mycophenolate mofetil</Semaphore>, ciclosporin, <Semaphore x="1244668" class="Medicine" value="Tacrolimus" score="1.00" ID="268063">tacrolimus </Semaphore>and <Semaphore x="1081705" class="Medicine" value="prednisoLONE" score="1.00" ID="291320">prednisolone </Semaphore>and did not provide a causality <Semaphore x="2397639" class="Procedure" value="Physical Examination" score="1.00" ID="C20989">assessment </Semaphore>between <Semaphore x="2766382" class="MedDRA LLT" value="Atrial fibrillation" score="1.00" ID="10003658"><Semaphore x="1544130" class="Disease or Finding" value="Arrhythmia" score="1.00" ID="C2881">arrhythmia </Semaphore>absoluta </Semaphore>and <Semaphore x="1081705" class="Medicine" value="prednisoLONE" score="1.00" ID="291320">prednisolone</Semaphore>.Follow up received on 17 May 2006: On 14 Apr 2006, the patient developed an <Semaphore x="3003427" class="MedDRA LLT" value="Hernia obstructive" score="1.00" ID="10061207">incarcerated <Semaphore x="2022961" class="Disease or Finding" value="Hernia" score="1.00" ID="C34685">hernia</Semaphore></Semaphore>, for which he was readmitted to hospital. There was an area of necrotic <Semaphore x="2068954" class="AnatomicStructure" value="Intestine" score="1.00" ID="C12736">small <Semaphore x="2068954" class="AnatomicStructure" value="Intestine" score="1.00" ID="C12736">intestine </Semaphore></Semaphore>which he had excised, following which this event improved. The investigator assessed this event to be life threatening. The investigator considered the <Semaphore x="3003427" class="MedDRA LLT" value="Hernia obstructive" score="1.00" ID="10061207">incarcerated <Semaphore x="2022961" class="Disease or Finding" value="Hernia" score="1.00" ID="C34685">hernia </Semaphore></Semaphore>due to the <Semaphore x="1405612" class="Disease or Finding" value="Abdominal Hernia" score="1.00" ID="C98700">abdominal hernia</Semaphore>.Follow up received on 15 May 2007: The dose of <Semaphore x="894462" class="Medicine" value="mycophenolate mofetil" score="1.00" ID="279461">mycophenolate mofetil </Semaphore>was <Semaphore x="1447179" class="Disease or Finding" value="Adjustment Disorder" score="1.00" ID="C92191">adjusted </Semaphore>to 2000 mg daily, <Semaphore x="1081488" class="Medicine - prednisoLONE - Dose" value="500mg" score="0.49" ID=""><Semaphore x="1081705" class="Medicine" value="prednisoLONE" score="1.00" ID="291320">prednisolone </Semaphore>to <Semaphore x="4644955591016450" class="Medicine - prednisoLONE - Dose" value="5 mg" score="0.49" ID="">5 mg </Semaphore></Semaphore><Semaphore x="4645419447484417" class="Medicine - prednisoLONE - Frequency" value="daily" score="0.74" ID="">daily</Semaphore>, and <Semaphore x="1244631" class="Medicine - Tacrolimus - Dose" value="4 mg" score="0.49" ID=""><Semaphore x="1244668" class="Medicine" value="Tacrolimus" score="1.00" ID="268063">tacrolimus </Semaphore>to <Semaphore x="5345649440587777" class="Medicine - Tacrolimus - Dose" value="4 mg" score="0.49" ID="">4 mg </Semaphore></Semaphore><Semaphore x="5345726749999105" class="Medicine - Tacrolimus - Frequency" value="daily" score="0.49" ID="">daily</Semaphore>. On an unknown date, the patient experienced <Semaphore x="1536307" class="Disease or Finding" value="Aortic Stenosis" score="1.00" ID="C50462">aortic valve stenosis</Semaphore>. This became serious on 29 Jan 2007 and the patient was hospitalised. Eighteen days later he died due to the event of <Semaphore x="1536307" class="Disease or Finding" value="Aortic Stenosis" score="1.00" ID="C50462">aortic stenosis</Semaphore>. The relapsing <Semaphore x="1405612" class="Disease or Finding" value="Abdominal Hernia" score="1.00" ID="C98700">abdominal hernia </Semaphore>and the <Semaphore x="2766382" class="MedDRA LLT" value="Atrial fibrillation" score="1.00" ID="10003658"><Semaphore x="1544130" class="Disease or Finding" value="Arrhythmia" score="1.00" ID="C2881">arrhythmia </Semaphore>absoluta </Semaphore>were persisting and <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">treatment </Semaphore>with <Semaphore x="894462" class="Medicine" value="mycophenolate mofetil" score="1.00" ID="279461">Mycophenolate Mofetil </Semaphore>(MMF), <Semaphore x="1081705" class="Medicine" value="prednisoLONE" score="1.00" ID="291320">Prednisolone </Semaphore>and <Semaphore x="1244668" class="Medicine" value="Tacrolimus" score="1.00" ID="268063">Tacrolimus </Semaphore>were ongoing. The investigator considered the <Semaphore x="1536307" class="Disease or Finding" value="Aortic Stenosis" score="1.00" ID="C50462">aortic valve stenosis </Semaphore>(fatal) to be unrelated to all study medications and stated that a possible alternative cause for the event was a pre existing underlying disease causing <Semaphore x="1722367" class="Disease or Finding" value="Cardiac Arrest" score="1.00" ID="C50479">cardiac <Semaphore x="2463617" class="Disease or Finding" value="Respiratory Arrest" score="1.00" ID="C101772">respiratory <Semaphore x="2840299" class="MedDRA LLT" value="Cardiac arrest" score="1.00" ID="10007515">cardiac arrest</Semaphore></Semaphore></Semaphore>. The investigator considered the <Semaphore x="2253052" class="Disease or Finding" value="Myocardial Infarction by ECG Finding" score="1.00" ID="C101589">myocardial infarction </Semaphore>and <Semaphore x="3003427" class="MedDRA LLT" value="Hernia obstructive" score="1.00" ID="10061207">incarcerated <Semaphore x="2022961" class="Disease or Finding" value="Hernia" score="1.00" ID="C34685">hernia </Semaphore></Semaphore>to be life threatening and the relapsing <Semaphore x="1405612" class="Disease or Finding" value="Abdominal Hernia" score="1.00" ID="C98700">abdominal hernia </Semaphore>to be medically significant. The <Semaphore x="2253052" class="Disease or Finding" value="Myocardial Infarction by ECG Finding" score="1.00" ID="C101589">myocardial infarction </Semaphore>was considered unrelated to MMF, ciclosporin, <Semaphore x="1081705" class="Medicine" value="prednisoLONE" score="1.00" ID="291320">prednisolone </Semaphore>and <Semaphore x="428474" class="Medicine" value="Daclizumab" score="1.00" ID="240020">daclizumab</Semaphore>. The relapsing <Semaphore x="1405612" class="Disease or Finding" value="Abdominal Hernia" score="1.00" ID="C98700">abdominal hernia </Semaphore>was considered related to MMF, ciclosporin and <Semaphore x="1081705" class="Medicine" value="prednisoLONE" score="1.00" ID="291320">prednisolone</Semaphore>, and unrelated to <Semaphore x="428474" class="Medicine" value="Daclizumab" score="1.00" ID="240020">daclizumab</Semaphore>. The <Semaphore x="2766382" class="MedDRA LLT" value="Atrial fibrillation" score="1.00" ID="10003658"><Semaphore x="1544130" class="Disease or Finding" value="Arrhythmia" score="1.00" ID="C2881">arrhythmia </Semaphore>absoluta </Semaphore>was unrelated to <Semaphore x="428474" class="Medicine" value="Daclizumab" score="1.00" ID="240020">daclizumab</Semaphore>, MMF, ciclosporin and <Semaphore x="1244668" class="Medicine" value="Tacrolimus" score="1.00" ID="268063">tacrolimus</Semaphore>. The <Semaphore x="3003427" class="MedDRA LLT" value="Hernia obstructive" score="1.00" ID="10061207">incarcerated <Semaphore x="2022961" class="Disease or Finding" value="Hernia" score="1.00" ID="C34685">hernia </Semaphore></Semaphore>was due to the <Semaphore x="1405612" class="Disease or Finding" value="Abdominal Hernia" score="1.00" ID="C98700">abdominal hernia </Semaphore>and was unrelated to the study medication.Follow up received 19 Jun 2009 from Roche, MCN 372972: On 30 Jun 2004, the patient commenced IV <Semaphore x="428474" class="Medicine" value="Daclizumab" score="1.00" ID="240020">daclizumab </Semaphore><Semaphore x="1840157263134721" class="Medicine - Daclizumab - Dose" value="170mg" score="0.49" ID="">170mg </Semaphore><Semaphore x="1840217392676865" class="Medicine - Daclizumab - Frequency" value="once" score="0.49" ID="">once</Semaphore>, <Semaphore x="894462" class="Medicine" value="mycophenolate mofetil" score="1.00" ID="279461">mycophenolate mofetil </Semaphore><Semaphore x="3841431634444289" class="Medicine - mycophenolate mofetil - Dose" value="2g" score="0.49" ID="">2g </Semaphore><Semaphore x="3841560483463169" class="Medicine - mycophenolate mofetil - Frequency" value="daily" score="0.49" ID="">daily</Semaphore>, <Semaphore x="423457" class="Medicine" value="cycloSPORINE" score="0.93" ID="243146">cyclosporine </Semaphore><Semaphore x="1818549282668545" class="Medicine - cycloSPORINE - Dose" value="340mg" score="0.49" ID="">340mg </Semaphore><Semaphore x="1818639476981761" class="Medicine - cycloSPORINE - Frequency" value="and" score="0.49" ID="">and </Semaphore><Semaphore x="1081705" class="Medicine" value="prednisoLONE" score="1.00" ID="291320">prednisolone </Semaphore><Semaphore x="4644955591016451" class="Medicine - prednisoLONE - Dose" value="500mg" score="0.49" ID="">500mg </Semaphore><Semaphore x="4645419447484418" class="Medicine - prednisoLONE - Frequency" value="once" score="0.49" ID="">once</Semaphore>. On postoperative day 1, intravenous <Semaphore x="1081705" class="Medicine" value="prednisoLONE" score="1.00" ID="291320">prednisolone </Semaphore>was changed to <Semaphore x="2336704" class="AnatomicStructure" value="Oral Cavity" score="1.00" ID="C12421">oral </Semaphore>at 75mg, once. The same day, <Semaphore x="2336704" class="AnatomicStructure" value="Oral Cavity" score="1.00" ID="C12421">oral </Semaphore><Semaphore x="1081705" class="Medicine" value="prednisoLONE" score="1.00" ID="291320">prednisolone </Semaphore>was again changed to intravenous 250mg once. The following day, the patient received <Semaphore x="2336704" class="AnatomicStructure" value="Oral Cavity" score="1.00" ID="C12421">oral </Semaphore><Semaphore x="1081488" class="Medicine - prednisoLONE - Dose" value="500mg" score="0.49" ID=""><Semaphore x="1081705" class="Medicine" value="prednisoLONE" score="1.00" ID="291320">prednisolone </Semaphore>at <Semaphore x="4644955591016449" class="Medicine - prednisoLONE - Dose" value="100mg" score="0.49" ID="">100mg </Semaphore></Semaphore><Semaphore x="4645419447484417" class="Medicine - prednisoLONE - Frequency" value="daily" score="0.74" ID="">daily</Semaphore>. On 14 Jul 2004, the dose of <Semaphore x="428474" class="Medicine" value="Daclizumab" score="1.00" ID="240020">daclizumab </Semaphore>was reduced to 85mg once per 2 weeks for four weeks. On 23 Jul 2004, the patient experienced <Semaphore x="2715903" class="MedDRA LLT" value="Acute myocardial infarction" score="1.00" ID="10000891">non <Semaphore x="2253052" class="Disease or Finding" value="Myocardial Infarction by ECG Finding" score="1.00" ID="C101589">STEMI </Semaphore>post <Semaphore x="2596409" class="Procedure" value="Surgical Procedure" score="1.00" ID="C15329">surgery </Semaphore>(<Semaphore x="2253052" class="Disease or Finding" value="Myocardial Infarction by ECG Finding" score="1.00" ID="C101589">non </Semaphore></Semaphore>
    <Semaphore x="2318602" class="Disease or Finding" value="Non-ST Elevation Myocardial Infarction by ECG Finding" score="1.00" ID="C80383">
     <Semaphore x="2253052" class="Disease or Finding" value="Myocardial Infarction by ECG Finding" score="1.00" ID="C101589">ST elevation <Semaphore x="3120463" class="MedDRA LLT" value="Myocardial infarction" score="1.00" ID="10028596">myocardial infarction</Semaphore></Semaphore></Semaphore>). On 13 Oct 2004, the dose of <Semaphore x="894462" class="Medicine" value="mycophenolate mofetil" score="1.00" ID="279461">mycophenolate mofetil </Semaphore>was reduced to 500mg daily due to '<Semaphore x="2724216" class="MedDRA LLT" value="Adverse event" score="1.00" ID="10060933">adverse event </Semaphore><Semaphore x="2638558" class="Disease or Finding" value="Toxicity" score="1.00" ID="C27990">toxicity</Semaphore>'. On 19 Oct 2004, <Semaphore x="2336704" class="AnatomicStructure" value="Oral Cavity" score="1.00" ID="C12421">oral </Semaphore><Semaphore x="1081705" class="Medicine" value="prednisoLONE" score="1.00" ID="291320">prednisolone </Semaphore>was changed to intravenous at 250mg daily. The next day, <Semaphore x="2336704" class="AnatomicStructure" value="Oral Cavity" score="1.00" ID="C12421">oral </Semaphore><Semaphore x="1081705" class="Medicine" value="prednisoLONE" score="1.00" ID="291320">prednisolone </Semaphore>was discontinued. On 22 Oct 2004, <Semaphore x="2336704" class="AnatomicStructure" value="Oral Cavity" score="1.00" ID="C12421">oral </Semaphore><Semaphore x="1081705" class="Medicine" value="prednisoLONE" score="1.00" ID="291320">prednisolone </Semaphore>was restarted at 100mg daily. On 27 Oct 2004, the event of <Semaphore x="2715903" class="MedDRA LLT" value="Acute myocardial infarction" score="1.00" ID="10000891">non <Semaphore x="2253052" class="Disease or Finding" value="Myocardial Infarction by ECG Finding" score="1.00" ID="C101589">STEMI </Semaphore></Semaphore>post <Semaphore x="2596409" class="Procedure" value="Surgical Procedure" score="1.00" ID="C15329">surgery </Semaphore>resolved. Cyclosporin was discontinued on 05 Nov 2004. On 16 Apr 2006, the event of <Semaphore x="2451967" class="Disease or Finding" value="Recurrent Disease, Distant Site" score="1.00" ID="C55073">relapsing </Semaphore><Semaphore x="1405612" class="Disease or Finding" value="Abdominal Hernia" score="1.00" ID="C98700">abdominal hernia </Semaphore>resolved. The next day, the patient experienced <Semaphore x="2253791" class="Disease or Finding" value="Myocardial Infarction" score="1.00" ID="C27996">myocardial infarct </Semaphore>and was hospitalized. On 03 May 2006, the event of <Semaphore x="2253791" class="Disease or Finding" value="Myocardial Infarction" score="1.00" ID="C27996">myocardial infarct </Semaphore>resolved. On 20 May 2006, <Semaphore x="894462" class="Medicine" value="mycophenolate mofetil" score="1.00" ID="279461">mycophenolate mofetil </Semaphore>was increased to 1000mg daily. On 29 Jan 2007, the patient experienced <Semaphore x="1536307" class="Disease or Finding" value="Aortic Stenosis" score="1.00" ID="C50462">aortic valve stenosis </Semaphore>which became serious and he was hospitalized. On 16 Feb 2007, the patient died due to <Semaphore x="1536307" class="Disease or Finding" value="Aortic Stenosis" score="1.00" ID="C50462">aortic valve stenosis</Semaphore>. The investigator assessed all the events as unrelated to the use of <Semaphore x="428474" class="Medicine" value="Daclizumab" score="1.00" ID="240020">daclizumab</Semaphore>. The event of <Semaphore x="2451967" class="Disease or Finding" value="Recurrent Disease, Distant Site" score="1.00" ID="C55073">relapsing </Semaphore><Semaphore x="1405612" class="Disease or Finding" value="Abdominal Hernia" score="1.00" ID="C98700">abdominal hernia </Semaphore>was related and all other events were unrelated to the use of <Semaphore x="894462" class="Medicine" value="mycophenolate mofetil" score="1.00" ID="279461">mycophenolate mofetil</Semaphore>, cyclosporin (Novartis <Semaphore x="1670730" class="Procedure" value="CAM Pharmacological or Biological Treatment" score="1.00" ID="C15906">drug</Semaphore>) and corticosteroids.Follow up received on 06 Dec 2012: The investigator confirmed that, the subject was <Semaphore x="1846062" class="Procedure" value="Diagnosis" score="1.00" ID="C15220">diagnosed </Semaphore>with <Semaphore x="2451967" class="Disease or Finding" value="Recurrent Disease, Distant Site" score="1.00" ID="C55073">relapsing </Semaphore><Semaphore x="1405612" class="Disease or Finding" value="Abdominal Hernia" score="1.00" ID="C98700">abdominal hernia </Semaphore>on 03 Nov 2004 and on 09 May 2006, the subject recovered from <Semaphore x="3003427" class="MedDRA LLT" value="Hernia obstructive" score="1.00" ID="10061207">incarcerated <Semaphore x="2022961" class="Disease or Finding" value="Hernia" score="1.00" ID="C34685">hernia</Semaphore></Semaphore>.</narrativeincludeclinical>
				<sendercomment>MAC: The events hernia obstructive and abdominal hernia can be possible explained as surgical complications, but the lack of relevant details excludes a meaningful medical assessment. A causal relationship to drug cannot be rule out.</sendercomment>
			</summary>
		</patient>
	</safetyreport>
</ichicsr></original></faers>